---
title: 'Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric
  acute lymphoblastic leukemia: results of a multicenter randomized trial'
date: '2024-08-08'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39113674/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240808182348&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Infections lead to substantial morbidity during treatment of acute lymphoblastic
  leukemia (ALL) in which the adaptive immune system gets severely affected, leading
  to declining serum immunoglobulin levels. The aim of this trial was to investigate
  whether intravenous immunoglobulin (IVIG) prophylaxis in pediatric patients with
  ALL prevents admissions for fever. This randomized controlled trial was a subtrial
  of the national Dutch multicenter ALL study. Patients aged 1-19 years with medium
  ...
disable_comments: true
---
Infections lead to substantial morbidity during treatment of acute lymphoblastic leukemia (ALL) in which the adaptive immune system gets severely affected, leading to declining serum immunoglobulin levels. The aim of this trial was to investigate whether intravenous immunoglobulin (IVIG) prophylaxis in pediatric patients with ALL prevents admissions for fever. This randomized controlled trial was a subtrial of the national Dutch multicenter ALL study. Patients aged 1-19 years with medium ...